Our Team
How We Started
Diagnostic Biochips was launched on the premise that users are ready for a turnkey multichannel extracellular recording system on par with laboratory assays and instruments found in other fields such as genetics. The foundational probe technology is based on Brian Jamieson and Fan Wu’s doctoral work at the University of Michigan, with several years of development funded in cooperation with the Howard Hughes Medical Institute/JFRC (2007-2016). We are located in Glen Burnie, Maryland (near BWI airport), which we half-jokingly describe as the emerging neurotech capital of the world.
Our Leadership
Our Progress at a Glance
Formation
Diagnostic Biochips emerged from engineering services company Scientific & Biomedical Microsystems (SBM) in 2013 to commercialize technology developed under contract with the Howard Hughes Medical Institute’s Janelia Research Campus. With over $6M of R&D funding from the NIH and DARPA, Diagnostic Biochips has been expanding our preclinical neurosensor’s capabilities.
Building Momentum
A lack of appropriately scaled and widely applicable tools to study structures at the neural network level was identified as one of the barriers to allowing scientists to develop a detailed, functional description of the brain. In 2014, a consortium of federal agencies including the NIH, NSF, DARPA, the FDA, reached the same conclusion. As a result, The Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative, a multi-decadal, multi-billion dollar program, was launched to accelerate the understanding of the brain, and advance therapies and cures for the growing burden of brain disease. We are proud to be aligned.
Current Focus
By accelerating the development and application of innovative technologies, researchers will be able to produce a revolutionary new picture of the brain that, for the first time, shows how individual cells and complex neural circuits interact in both time and space. Long desired by researchers seeking new ways to treat, cure and even prevent brain disorders, this picture will fill major gaps in our current knowledge and provide unprecedented opportunities for exploring exactly how the brain enables the human body to record, process, utilize, store and retrieve vast quantities of information, all at the speed of thought.
Company Progression Timeline
-
2003: Brian Jamieson defends thesis on active neural probesBrian Jamieson defends thesis on active neural probes
2012: DBC IncorporatedDBC Incorporated
2013: SBIR grant from NIAAA to measure interaction of ethanol with neuronal circuitsSBIR grant from NIAAA: SBIR grant from NIAAA to measure interaction of ethanol with neuronal circuits
2013: SBIR Grant from NIDA: effect of drug abuse on brain circuitrySBIR grant from NIAAA: SBIR Grant from NIDA: effect of drug abuse on brain circuitry
2013: Distribution agreement with Cambridge Neurotech and sale of first productDistribution agreement with Cambridge Neurotech and sale of first product
2014: SBIR grant from NHLBI: continuous measurement of chemotherapeutic drugsSBIR grant from NHLBI: continuous measurement of chemotherapeutic drugs
2014: Fan Wu defends thesis on optogenetics probesFan Wu defends thesis on optogenetics probes
2015: SBIR grant (Brain Initiative) from NIMH for continuous psychiatric drug monitoringSBIR grant (Brain Initiative) from NIMH for continuous psychiatric drug monitoring
2015: License and Distribution Agreement with Howard Hughes Medical InstituteLicense and Distribution Agreement with Howard Hughes Medical Institute
2016: Review paper on Point of care technology in IEEE Journal of Translational Research in Health and MedicineReview paper on Point of care technology in IEEE Journal of Translational Research in Health and Medicine
2016: VP of New Product Development Fan Wu, Ph.D. joins companyVP of New Product Development Fan Wu, Ph.D. joins company
2017: DARPA grant for continuous measurement of cytokinesDARPA grant for continuous measurement of cytokines
2017: Chemosensing Technology Featured in Journal of Materials ChemistryChemosensing Technology Featured in Journal of Materials Chemistry
2018: US Patent issued: In Vivo BiosensorUS Patent issued: In Vivo Biosensor
2019: US Patent issued: Optical Neural probeUS Patent issued: Optical Neural probe
2019: Probe Technology Featured in Frontiers in NeuroscienceProbe Technology Featured in Frontiers in Neuroscience
2019: Review Paper Authored on Continuous Monitoring in Translational ResearchReview Paper Authored on Continuous Monitoring in Translational Research
2019: CEO Greg Alden joins companyCEO Greg Alden joins company
2020: Probe User Michael Long Featured on cover of Cell for Work Using DBC probeProbe User Michael Long Featured on cover of Cell for Work Using DBC probe
2021: VP of Marketing Nancy Palmer joins companyVP of Marketing Nancy Palmer joins company
2021: VP of Sales, Scott Smith, Ph.D. joins companyVP of Sales, Scott Smith, Ph.D. joins company
2021: Series A Financing CompletedSeries A Financing completed
2021: Integrated 64 and 128 Probe Product ReleasedIntegrated 64 and 128 Probe Product Released
Get in Touch
We’d love to talk to you about your needs and how we can help.
Diagnostic Biochips Headquarters
802 Cromwell Park Drive, Suite N, Glen Burnie, MD 21061
9am-5pm EST
Diagnostic Biochips Headquarters
802 Cromwell Park Drive, Suite N, Glen Burnie, MD 21061
9am-5pm EST